CHIC 2026 Honors Top Healthcare Deals and Financings at Annual Awards Gala

Wednesday, Apr 1, 2026 9:37 pm ET1min read
GSK--
VOR--

The 12th Annual China Healthcare Investment Conference (CHIC 2026) recognized outstanding achievements in healthcare investment, financing, and deal-making over the past year. Award winners included Insilico Medicine for IPO of the Year, Kailera Therapeutics and Vor Bio for Private Financing of the Year, and Hengrui Pharma-GSK and Innovent-Takeda for Deal of the Year. The conference, held on March 23-24, brought together senior decision-makers from venture capital, private equity, and pharmaceutical industries to discuss innovation in healthcare.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet